Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,670.00
Ask:
5,690.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Third quarter trading statement

7 Feb 2019 07:00

RNS Number : 3092P
Cranswick PLC
07 February 2019
 

7 February 2019

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides an update on trading for the three months to 31 December 2018.

 

Current trading

As expected, revenue for the quarter was 2 per cent lower compared to the equivalent 13-week period in the previous financial year. Strong growth in poultry and continental products was offset by lower sales from other, pork related, categories.

 

The UK pig price continued to ease during the period, ending the quarter 7 per cent lower than at the same stage last year. This downward trend is being reflected in selling prices.

 

Performance over the festive period was robust, reflecting a well-executed Christmas plan, strong cost control and operational efficiencies.

 

Investment

The Group continues to invest at record levels across its asset base to increase capacity, add new capability and drive further operating efficiencies, whilst maintaining industry leading standards at all its facilities.

 

Construction of the Group's new poultry processing facility in Eye, Suffolk, is continuing to plan with the exterior building works nearing completion and commissioning anticipated towards the end of the next financial year as previously indicated.

 

We are pleased to report that the Group has agreed a long-term supply agreement with Wm Morrison Supermarkets plc to supply fresh poultry from the new Eye facility. We will also shortly start supplying the same customer with a range of cooked poultry products from our added value poultry facility in Hull.

 

Financial position

Net debt increased during the quarter, reflecting the customary seasonal increase in working capital and ongoing expenditure on capital projects, and ended the period in line with the same stage last year.

 

The Group's borrowings continue to be managed conservatively with committed, unsecured facilities of £160 million providing considerable headroom to support the Group's growth strategy.

 

Outlook

The Board's expectations for the Group's trading performance in the current year are unchanged.

 

For the following financial year, the Group's operating margin is likely to decline, reflecting the potentially challenging commercial landscape, together with start-up and commissioning costs associated with the new Eye Facility, only partly offset by management actions.

 

Notwithstanding these short-term challenges, our new Eye and existing added value, poultry facilities and our broadening customer base, provide a solid platform to further develop our poultry business and drive future growth in this attractive and expanding protein category.

 

The Board is confident that continued focus on the strengths of the Company, which include its long-standing customer relationships, breadth and quality of products, robust financial position and industry leading asset infrastructure, will support the further successful development of the Group over the longer term.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement on 21 May 2019.

 

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Finance Director

 

 

 

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2018 showed revenue of £1,465m and profit before tax of £88.0m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVAFSIRIIA
Date   Source Headline
3rd Jun 20263:37 pmRNSDirector/PDMR Shareholding
1st Jun 20268:41 amRNSTotal Voting Rights
26th May 202610:27 amRNSDirector/PDMR Shareholding
22nd May 20263:39 pmRNSDirector/PDMR Shareholding
21st May 20263:27 pmRNSDirectors Dealing
19th May 20267:00 amRNSPreliminary Results
13th May 202611:03 amRNSIssue of Equity/Admission to Trading
1st May 202611:53 amRNSTotal Voting Rights
22nd Apr 20266:05 pmRNSDirector/PDMR Shareholding
1st Apr 20263:44 pmRNSTotal Voting Rights
31st Mar 202612:33 pmRNSIssue of Equity/Admission to Trading
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
23rd Mar 202610:31 amRNSDirector/PDMR Shareholding
12th Mar 202612:07 pmRNSHolding(s) in Company
10th Mar 20264:47 pmRNSHolding(s) in Company
4th Mar 20265:17 pmRNSHolding(s) in Company
2nd Mar 20263:24 pmRNSHolding(s) in Company
2nd Mar 20263:21 pmRNSTotal Voting Rights
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:18 pmRNSDirector/PDMR Shareholding
26th Feb 20263:55 pmRNSHolding(s) in Company
24th Feb 202611:31 amRNSDirector/PDMR Shareholding
18th Feb 20265:55 pmRNSHolding(s) in Company
18th Feb 202612:11 pmRNSHolding(s) in Company
2nd Feb 20263:54 pmRNSTotal Voting Rights
30th Jan 20266:10 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSHolding(s) in Company
28th Jan 20265:59 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSThird quarter trading statement
23rd Jan 202611:27 amRNSDirector/PDMR Shareholding
22nd Jan 20264:51 pmRNSHolding(s) in Company
22nd Jan 20263:17 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202610:52 amRNSTotal Voting Rights
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20259:15 amRNSHolding(s) in Company
1st Dec 202510:49 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.